Audentes Therapeutics, Inc. News
Audentes Therapeutics Soars on Astellas Pharma's $3 Billion Purchase
Astellas Pharma says it's going to buy the clinical stage biotech company for $3 billion in cash.
Markets Keep Eye on China Presidential Speech; Biotechs Bounce -- ICYMI
Here's what you need to know for Monday, April 9.
Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers
The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.
Insiders Are Loading Up on Twitter TWTR, Biogen BIIB & More
Insiders at Twitter, Biogen and three other companies have been snapping up shares of their own stock lately.
Elon Musk Says Only Two Things Could Make Him Leave Tesla
Tesla CEO Musk discusses succession plans and Twitter with shareholders.
Caesars Inches Closer to Huge Las Vegas Strip Move
The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.
Elon Musk Has Bad News About Tesla's Cybertruck
Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023